Friday, 14 February 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 14 February 2025
News

HCPs pick best pharma in oncology

Posted 29 January 2025 AM

AstraZeneca has continued its run to take the crown as the new perception leader in oncology, with HCPs ranking it the highest across five categories.

ZoomRx interviewed more than 300 oncologists, with 40 per cent of them in hemato-oncology, on their perception of 19 manufacturers of oncology treatments. The survey measured their perceptions on innovation, patient-centricity, reputation, HCP centricity, and promotional practices, with six countries contributing to the global score. The results were published in the Global Pharma Perception Report Oncology.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (19)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (4)

Other (14)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.